Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 16,733 | 17,021 | 8,795 | 10,727 | 7,178 |
| Cost of Goods | 7,269 | 8,521 | 5,534 | 4,809 | 4,391 |
| Gross Profit | 9,464 | 8,500 | 3,261 | 5,918 | 2,787 |
| Operating Expenses | 18,941 | 17,504 | 17,359 | 17,031 | 15,699 |
| Operating Income | -9,477 | -9,004 | -14,098 | -11,113 | -12,912 |
| Interest Expense | 8 | 68 | 815 | N/A | N/A |
| Other Income | 1,881 | -578 | 14,913 | 11,113 | 12,912 |
| Pre-tax Income | -7,604 | -9,650 | N/A | N/A | N/A |
| Income Tax | 104 | 43 | N/A | N/A | N/A |
| Net Income Continuous | -7,708 | -9,693 | 15,018 | -10,552 | -12,376 |
| Net Income | $-7,708 | $-9,693 | $15,018 | $-10,552 | $-12,376 |
| EPS Basic Total Ops | -1.04 | -1.30 | 2.60 | -2.60 | -3.25 |
| EPS Basic Continuous Ops | -1.04 | -1.30 | 2.60 | -2.60 | -3.25 |
| EPS Diluted Total Ops | -1.04 | -1.30 | 2.60 | -2.60 | -3.25 |
| EPS Diluted Continuous Ops | -1.04 | -1.30 | 2.60 | -2.60 | -3.25 |
| EBITDA(a) | $-6,892 | $-8,962 | $-13,551 | $-10,045 | $-12,043 |